Michael Wells
Healthcare Entrepreneur and Investor
Professional Overview
Michael Wells is a seasoned healthcare entrepreneur and investor with a proven track record of founding, leading, and growing successful life sciences companies. As the Founder and Managing Director of Princeton Biopharma Capital Partners, LLC, he leverages his extensive industry expertise to identify and invest in promising healthcare startups and technologies.
Current Roles
Chairman/CEO at Kaléo (2023-10-01 to Present)
- Provides strategic leadership and oversight as the Chairman and CEO of Kaléo, a specialty pharmaceutical company focused on developing innovative products for the treatment of life-threatening conditions.
- Responsible for driving the company's overall vision, business strategy, and operational execution to further expand its product portfolio and market reach.
Chairman, CEO and Lead Investor at Fidelis Animal Health (2017-07-01 to Present)
- Serves as the Chairman, CEO, and lead investor of Fidelis Animal Health, a rapidly growing animal health company dedicated to developing advanced veterinary products and services.
- Oversees the company's strategic direction, product development, and commercial expansion to address unmet needs in the animal healthcare industry.
Career Progression
Founder and Managing Director at Princeton Biopharma Capital Partners, LLC (2010-06-01 to Present)
- Founded Princeton Biopharma Capital Partners, LLC, a boutique investment firm focused on identifying and investing in promising early-stage healthcare companies.
- Leads the firm's investment strategy, due diligence process, and portfolio management to drive growth and value creation for portfolio companies.
CEO and Founder at Aton Pharma, Inc. (2006-10-01 to 2010-05-01)
- Served as the CEO and founder of Aton Pharma, Inc., a specialty pharmaceutical company that developed and commercialized innovative medications for the treatment of rare and orphan diseases.
- Guided the company through its early-stage development, product launches, and successful acquisition by a larger pharmaceutical firm.
Vice President, Marketing at Lathian Systems, Inc. (2000-01-01 to 2004-01-01)
- Held the role of Vice President of Marketing at Lathian Systems, Inc., a leading provider of healthcare-focused technology and digital marketing solutions.
- Contributed to the company's growth and market expansion by developing and executing effective marketing strategies to support the sales of its suite of products and services.
Education
Michael Wells holds a Bachelor of Science degree in Biochemistry from the University of Florida, where he graduated with honors.
Areas of Expertise
- Healthcare entrepreneurship and venture investing
- Specialty pharmaceutical product development and commercialization
- Animal health product innovation and market expansion
- Strategic leadership and executive management
- Identifying and capitalizing on emerging healthcare trends and opportunities
Professional Impact
- Successfully founded, led, and grew multiple healthcare startups, including Aton Pharma, which was acquired by a larger pharmaceutical company.
- Serves as the Chairman and CEO of Kaléo, a specialty pharmaceutical company focused on developing innovative treatments for life-threatening conditions.
- Leads Fidelis Animal Health as the Chairman, CEO, and lead investor, driving the company's growth and impact in the animal healthcare industry.
- Established Princeton Biopharma Capital Partners, LLC, a boutique investment firm that has invested in and supported the development of numerous promising healthcare companies.
Conclusion
With his extensive experience as a healthcare entrepreneur, investor, and industry leader, Michael Wells is poised to continue making a significant impact in the life sciences and animal health sectors. His proven track record of founding and leading successful companies, coupled with his strategic vision and investment acumen, position him as a valuable partner and advisor for healthcare startups and established organizations alike.
